Ugt1a1 gene
Case report: multiple UGT1A1 gene variants in a patient with Crigler-Najjar syndrome
5
Impact of UGT1A1 gene polymorphisms on plasma dolutegravir trough concentrations and neuropsychiatric adverse events in Japanese individuals infected with HIV 1
8
Variants in the UGT1A1 Gene and the Risk of Pediatric Nonalcoholic Fatty Liver Disease
9
UGT1A1 gene mutation as a marker indicating there is a high risk of Gilbert's syndrome: Theoretical and applied aspects
7
UGT1A1 gene and neonatal hyperbilirubinemia: a preliminary study from Bengkulu, Indonesia
6
Prevalence of Gilbert Syndrome in Bangladesh
9
Original Article Association between hepatic iron deposition, and serum bilirulin levels, mutations of UGT1A1 and HFE gene in patients with hereditary unconjugated hyperbilirubinemia
10
Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer
13
Coexpression of Gene Polymorphisms Involved in Bilirubin Production and Metabolism
9
Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1*6 or UGT1A1*28
10
Relationship between <em>UGT1A1*6/*28</em> gene polymorphisms and the efficacy and toxicity of irinotecan-based chemotherapy
11
Clinical significance of <em>UGT1A1</em> gene polymorphisms on irinotecan-based regimens as the treatment in metastatic colorectal cancer
9
Association of Neonatal Hyperbilirubinemia With Bilirubin UDP-Glucuronosyltransferase Polymorphism
6
Polymorphisms of the uridine-diphosphoglucuronosyltransferase 1A1 gene and coronary artery disease
10
The relationship between <em>UGT1A1</em> gene polymorphism and irinotecan effect on extensive-stage small-cell lung cancer
9
Crigler-Najjar Syndrome: A Rare Fatality
9
Relationship between UGT1A1*6/*28 polymorphisms and severe toxicities in Chinese patients with pancreatic or biliary tract cancer treated with irinotecan-containing regimens
7
Risk assessment of gene variants for neonatal hyperbilirubinemia in Taiwan
5
Analysis of pharmacogenetic traits in two distinct South African populations
18
UGT1A1 polymorphisms in cancer: impact on irinotecan treatment
8